BB

Biji Bijumon

Active Director Director DIN 11110336
DIN 11110336 First appointment May 2025 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value •••• Premium profile

About Biji Bijumon

Data last updated:

Biji Bijumon is a Director at Cropmaxx Agriclinic Private Limited (since 2025). The company operates in Trading. Cropmaxx Agriclinic Private Limited reported revenue of ₹15.4 Lakh (FY 2021).

DIN 11110336
Primary Designation Director
Industry Trading
First Appointment 16 May 2025
Oldest Company Age 6 yrs
Largest company Cropmaxx Agriclinic Private Limited · ₹15.4 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cropmaxx Agriclinic Private Limited U51909KL2020PTC065407
Director16 May 20252020₹15.4 Lakh (FY 2021)Active

Board colleagues of Biji Bijumon

Directorship timeline

Open interactive timeline →
Cropmaxx Agriclinic Private Limited
Premium access

Shareholding and investment profile for Biji Bijumon

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biji Bijumon

Biji Bijumon currently holds 1 directorship: Cropmaxx Agriclinic Private Limited (Director, since 16 May 2025, revenue ₹15.4 Lakh (FY 2021)).

Biji Bijumon was first appointed on 16 May 2025 as Director at Cropmaxx Agriclinic Private Limited.

The current boards of Biji Bijumon's companies include Bijumon Kallooparambil Prabhakaran (Cropmaxx Agriclinic Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available